Ivax Shores Up Two Additional Paclitaxel Makers

June 2001
Chemical Market Reporter;6/4/2001, Vol. 260 Issue 23, p3
Trade Publication
Reports on the decision of the United States Food and Drug Administration (FDA) to approve two additional drug makers to manufacture the Onxol or paclitaxel drug of Ivax Corp. Failure of Ivax to meet the increased demand for Onxol; Significance of the FDA decision to Ivax; Pharmaceutical companies in North America which have publicly announced production of the paclitaxel API.


Related Articles

  • Federal Appeals Court Overturns FDA Approval of Generic Taxol. Hess, Glenn // Chemical Market Reporter;11/12/2001, Vol. 260 Issue 17, p1 

    Reports that the United States (U.S.) Court of Appeals has contested the approval of the U.S. Food & Drug Administration for a generic version of the cancer drug Taxol. Reaction of Ivax Corp., who sells the generic drug paclitaxel, on the ruling of the court; How sales from Taxol contribute to...

  • Ivax Gains Favorable Ruling in Taxol Dispute.  // Chemical Market Reporter;09/11/2000, Vol. 258 Issue 11, p17 

    Reports on the decision of the United States Food & Drug Administration to de-list the anti-cancer drug paclitaxel of Ivax Corp. Details on the court decision; Validity of the anti-cancer drug patent; Information on the drug patent requirement set by the federal agency.

  • Pharma & Fine Chemicals: Market Briefs.  // Chemical Market Reporter;06/28/99, Vol. 255 Issue 26, p14 

    Presents news briefs about the market for pharmaceuticals and fine chemicals. Approval from the United States Food and Drug Administration (FDA) received by Ivax Corporation; Fumaric acid offered by Balchem Encapsulates; FDA's approval of Taro Pharmaceutical Industries Ltd.'s ketoconazole tablets.

  • Psychosis Update.  // PharmaWatch: CNS;Feb2006, Vol. 5 Issue 2, p10 

    The article reports on news and developments concerning the pharmaceutical industry. Ivax Corp. has received a final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated drug application for a 200 milligram dosage clizapine tablet for the treatment of schizophrenia....

  • Generics Watch. Roller, Kim; Frederick, James // Drug Store News;3/6/2000, Vol. 22 Issue 3, p16 

    Presents news briefs on the pharmaceutical industry in the United States (US) as of March 6, 2000. Drug application approved by the Food and Drug Administration from IVAX Corp.; Marketing agreement signed by Amide Pharmaceuticals Inc. and Bertek Pharmaceuticals Inc., a subsidiary of Mylan...

  • IVAX GETS FINAL APPROVAL FOR METFORMIN.  // Biotech Business;Mar2002, Vol. 15 Issue 3, p6 

    Reports on the approval received by IVAX Corp. from U.S. Food and Drug Administration for its Abbreviated New Drug Application for sales of metformin hydrochloride tablets.

  • Ivax next in line to market generic Celexa.  // PharmaWatch: CNS;January 2005, Vol. 4 Issue 1, p10 

    Reports that shares in generic drugs manufacturer Ivax Corp. have seen a slight increase after it announced the receipt of final approval for its Celexa-equivalent antidepressant application in the U.S. Approval of the drug application by the U.S. Food and Drug Administration; Availability of...

  • Multiple Sclerosis Update.  // PharmaWatch: CNS;Mar2005, Vol. 4 Issue 3, p5 

    The article offers news briefs related to the pharmaceutical industry. Serono and Ivax Corp. have disclosed their plans to begin a phase III clinical trial with multiple sclerosis treatment Mylinax. Transition Therapeutics Inc. has begun enrolling patients for phase II study of its interferon...

  • Ivax's lisinopril gets tentative OK.  // Drug Store News;1/21/2002, Vol. 24 Issue 1, p37 

    Reports the tentative approval by the United States Food and Drug Administration of the lisinopril tablets produced by Ivax. Treatment indication of the drug.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics